MicroRNA 研究工具、诊断和治疗：全球市场

全球微小RNA（microRNA）研究工具市场规模将从2023年的6.642亿美元增长到2028年的8.83亿美元，预测期内復合年增长率为5.9%。

基于 microRNA 的定量逆转录 PCR (RT-qPCR) 领域预计将从 2023 年的 2.11 亿美元增长到 2028 年的 2.772 亿美元，复合年增长率为 5.6%。此外，基于 microRNA 的下一代测序 (NGS) 技术领域将从 2023 年的 1.411 亿美元增长到 2028 年的 2.04 亿美元，预计在预测期内復合年增长率为 7.6%。

在本报告中，我们调查了microRNA研究工具/诊断/治疗市场、市场背景/概述、市场影响因素分析、市场规模转变/预测、每个细分/区域的详细分析、ESG的发展和新兴市场。它总结了技术和新兴趋势、管道分析、竞争格局、主要参与者的概况等。

目录

第1章简介

第2章总结/要点

• 市场预测
• 市场亮点

第3章市场概况

• 背景：遗传物质
• RNA类型
• 信使RNA (mRNA)
• 核醣体 RNA (rRNA)
• 转移RNA (tRNA)
• 小干扰RNA (siRNA)
• 小核仁 RNA (snoRNA)
• PIWI 相互作用 RNA (piRNA)
• 微小RNA（miRNA）
• 概述
• microRNA研究的历史
• 微小RNA生物发生
• microRNA的功能
• microRNA的应用
• 研究工具
• microRNA在治疗中的应用
• microRNA在诊断中的应用
• 生物信息学：在 microRNA 研究中的应用
• 计算工具
• miRDB
• TargetScan
• DIANA-microT-CDS
• miRTargetLink 2.0
• RNA22 v2
• TargetMiner
• RNAhybrid
• 微小RNA数据库
• miRBase
• DeepBase
• 微小RNA图谱
• 植物 MicroRNA 数据库 (PMRD)

第4章市场动态

• 市场促进因素
• 市场挑战

第5章市场细分：按技术类型

• 市场概况
• 定量逆转录聚合酶炼式反应 (RT-qPCR)
• 新一代测序 (NGS)
• 微阵列
• 分离纯化工具
• 原位杂交 (ISH) 和 Northern 印迹
• 其他 microRNA 工具
• 微小RNA模拟物
• 微小RNA抑製剂
• 阿戈米尔
• 按技术类型分類的市场收入
• RT-qPCR
• 新一代测序 (NGS)
• 微阵列
• 分离纯化工具
• 原位杂交 (ISH) 和 Northern 印迹
• 其他工具

第6章市场细分：按最终用户分类

• 市场概况
• 学术机构及其他研究机构
• 生命科学产业
• 治疗
• 诊断
• 微小RNA服务提供商
• 市场收入：按最终用户分类
• 学术和其他研究机构：按技术类型
• 生命科学行业市场，按技术类型
• MicroRNA 服务提供商市场，按技术类型

第7章市场细分：按用途

• 市场概况
• 癌症
• 心血管疾病
• 神经系统疾病
• 代谢性疾病
• 免疫性疾病
• 其他疾病
• 市场收入：按用途
• 癌症
• 心血管疾病
• 神经系统疾病
• 代谢紊乱
• 免疫性疾病
• 其他疾病

第8章市场细分：按地区

• 市场概况
• 市场收入：按地区
• 北美
• 欧洲
• 亚太地区
• 其他地区

第9章ESG发展

• ESG：简介
• MicroRNA 工具和服务行业的可持续性：ESG 视角
• 主要 ESG 问题
• 消费者的 ESG 意识
• ESG绩效分析
• 案例分析
• BCC 的一般评论

第10章新趋势和新技术

• 新兴技术和市场趋势
• 用于无创健康监测的循环 microRNA 诊断
• 越来越多地采用数字 PCR (dPCR)
• RNA测序

第11章临床试验分析

• 概述
• 管道分析

第12章竞争格局

• 概述
• 主要企业排名
• M&A

第13章公司简介

• ABCAM PLC
• AGILENT TECHNOLGIES INC.
• BIO-RAD LABORATORIES INC.
• CD GENOMICS
• DANAHER
• F. HOFFMANN-LA ROCHE AG
• GENECOPOEIA INC.
• ILLUMINA INC.
• MERCK KGAA
• NANOSTRING TECHNOLOGIES INC.
• QIAGEN
• REGULUS THERAPEUTICS
• THERMO FISHER SCIENTIFIC INC.
• TAKARA BIO INC.

Highlights:

The global market for microRNA (miRNA) research tools is estimated to increase from $664.2 million in 2023 to $883.0 million by 2028, at a compound annual growth rate (CAGR) of 5.9% from 2023 through 2028.

The global market for miRNA based quantitative reverse transcription PCR (RT-qPCR) is estimated to increase from $211.0 million in 2023 to $277.2 million by 2028, at a CAGR of 5.6% from 2023 through 2028.

The global market for miRNA based next-generation sequencing (NGS) technology is estimated to increase from $141.1 million in 2023 to $204.0 million by 2028, at a CAGR of 7.6% from 2023 through 2028.

Report Scope:

The research study aims to thoroughly assess and analyze the miRNA research tools, diagnostics and therapeutics market; revenue forecasts; and future trends globally and provide strategic recommendations for the success of the market participants. This study focuses on the global market of miRNA tools and provides an updated review including its applications in various arenas of diagnostics and therapeutics. The report deals with miRNA tools covering technologies used in the biomedical industry. These products are miRNA quantitative reverse transcription-PCR, next-generation sequencing, microarray, fluorescent in situ hybridization, isolation and purification tools and other tools like inhibitors, probes and vectors.

The report also covers miRNA tools by end user and application. The end users for miRNA tools are categorized as academic and other research institutes, life science industry, and service sectors. The report covers market application areas, such as cancer, cardiovascular diseases, immune diseases, neurological disorders, metabolic disorders, and others (virology, liver diseases, genetic diseases among others).

The scope of the study is global. Current and projected market forecasts during the forecast period (2023 to 2028) are discussed. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by technology type, end user, application and region from 2023 through 2028.

The report also includes an analysis of leading and emerging competitors in the current worldwide miRNA research tools, diagnostics and therapeutics market. Profiles of manufacturers of leading products as well as biotechnology companies with novel products in development, are analyzed to define the specific product strategies employed. This report also assesses emerging trends and technologies in the market.

Report Includes:

• 33 data tables and 43 additional tables
• An up-to-date overview and industry analysis of the global markets for microRNA (miRNA) research tools, diagnostics and therapeutics
• Analyses of the global market trends, with historical market revenue data (sales figures) for 2020-2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
• Estimation of the actual market size and revenue forecast for the global miRNA tools markets, and corresponding market share analysis based on technology type, application (therapeutic area), end user, and region
• Updated information on key market drivers and opportunities, industry shifts and regulations, and other region and industry specific macroeconomic variables that will influence this market demand in the coming years (2023-2028)
• Insight into the recent industry structure, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis
• Review of the selected new miRNA products, research tools and diagnostics services, recent drug candidates, clinical trial applications, and new trends and developments in the biomedical industry
• Examination of the extensive portfolio of miRNA pathway drug candidates, some already in Phase II clinical trials, showing promising clinical data in various arenas of diagnostics and therapeutics, including cancer, hepatitis infections, and cardiovascular diseases etc.
• Identification of leading and emerging competitors in the current worldwide market for miRNA research tools, diagnostics, and therapeutics, and analysis of their competitive landscape based on recent developments and segmental revenues
• Descriptive company profiles of the leading global players, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Illumina Inc., F. Hoffmann-La Roche AG, Merck KGaA, Qiagen N.V., and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Methodology and Information Sources
• What's New in This Update?
• Geographic Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Highlights of the MicroRNA Research Tools, Diagnostics and Therapeutics Markets

Chapter 3 Market Overview

• Background: Genetic Material
• Types of RNA
• Messenger RNA (mRNA)
• Ribosomal RNA (rRNA)
• Transfer RNA (tRNA)
• Small Interfering RNAs (siRNA)
• Small Nucleolar RNA (snoRNA)
• PIWI-interacting RNAs (piRNAs)
• MicroRNAs (miRNAs)
• Overview
• History of MicroRNA Research
• Biogenesis of MicroRNA
• The Function of MicroRNA
• Applications of MicroRNA
• Research Tools
• MicroRNA in Therapeutics
• MicroRNA in Diagnostics
• Bioinformatics: Applications in MicroRNA Research
• Computational Tools
• miRDB
• TargetScan
• DIANA-microT-CDS
• miRTargetLink 2.0
• RNA22 v2
• TargetMiner
• RNAhybrid
• MicroRNA Databases
• miRBase
• DeepBase
• miRNAMap
• Plant microRNA Database (PMRD)

Chapter 4 Market Dynamics

• Market Drivers
• Developments in Analytical Technologies and Assay Methods
• Robust Funding Environment for Biomedical Research
• Increasing Incidence of Chronic Diseases
• Growing Number of Clinically Relevant miRNAs
• Market Challenges
• High Investment Cost
• High Failure Rate
• Challenges Associated with microRNA Based Therapeutics Development
• Lack of Skilled Professionals

Chapter 5 Market Breakdown by Technology Type

• Market Overview
• Quantitative Reverse Transcription Polymerase Chain Reaction (RT-qPCR)
• Next-Generation Sequencing (NGS)
• Microarray
• Isolation and Purification Tools
• In Situ Hybridization (ISH) and Northern Blotting
• Other miRNA Tools
• MicroRNA Mimics
• MicroRNA Inhibitors
• Agomirs/Antagomirs
• Market Revenue by Technology Type
• RT-qPCR
• Next-generation Sequencing (NGS)
• Microarray
• Isolation and Purification Tools
• In Situ Hybridization (ISH) and Northern Blotting
• Other Tools

Chapter 6 Market Breakdown by End User

• Market Overview
• Academic and Other Research Institutes
• Life Science Industry
• Therapeutics
• Diagnostics
• miRNA Service Providers
• Market Revenue by End User
• Academic and Other Research Institutes Market, by Technology Type
• Life Science Industry Market, by Technology Type
• miRNA Service Providers Market, by Technology Type

Chapter 7 Market Breakdown by Application

• Market Overview
• Cancer
• Cardiovascular Diseases
• Neurological Disorders
• Metabolic Diseases
• Immune Disorders
• Other Diseases
• Market Revenue by Application
• Cancer
• Cardiovascular Diseases
• Neurological Disorders
• Metabolic Disorders
• Immune Disorders
• Other Diseases

Chapter 8 Market Breakdown by Region

• Market Overview
• Market Revenue by Region
• North America
• Market Revenue, by Technology Type
• Europe
• Market Revenue, by Technology Type
• Asia-Pacific
• Market Revenue, by Technology Type
• Rest of the World (RoW)
• Market Revenue, by Technology Type

Chapter 9 ESG Development

• Introduction to ESG
• Sustainability in miRNA Tools and Services Industry: An ESG Perspective
• Key ESG Issues
• Consumer Attitudes Towards ESG
• Industry ESG Performance Analysis
• Case Study
• Concluding Remarks from BCC

Chapter 10 Emerging Trends and Technologies

• Emerging Technologies and Trends in the Market
• Circulating miRNA Diagnostics for Non-invasive Health Monitoring
• Increasing Adoption of Digital PCR (dPCR)
• RNA-Sequencing

Chapter 11 Clinical Trials Analysis

• Overview
• Pipeline Analysis

Chapter 12 Competitive Landscape

• Overview
• Leading Market Players Ranking
• Mergers and Acquisitions

Chapter 13 Company Profiles

• ABCAM PLC
• AGILENT TECHNOLGIES INC.
• BIO-RAD LABORATORIES INC.
• CD GENOMICS
• DANAHER
• F. HOFFMANN-LA ROCHE AG
• GENECOPOEIA INC.
• ILLUMINA INC.
• MERCK KGAA
• NANOSTRING TECHNOLOGIES INC.
• QIAGEN
• REGULUS THERAPEUTICS
• THERMO FISHER SCIENTIFIC INC.
• TAKARA BIO INC.

List of Tables

• Summary Table : Global Market for miRNA Tools, by Technology Type, Through 2028
• Table 1 : Deoxyribonucleic Acid Vs. Ribonucleic Acid
• Table 2 : RNA Types and Their Functions
• Table 3 : A Comparison Among Small Molecules, Protein-based and miRNA-based Drugs
• Table 4 : Comparison of Various MicroRNA Detection Methods
• Table 5 : NIH Funding for Selected Research Categories, Through 2023
• Table 6 : Terminated/Suspended microRNA Drug Candidates
• Table 7 : NGS vs. qPCR vs. Microarrays: A Detailed Comparison
• Table 8 : Global Market for miRNA Tools, by Technology Type, Through 2028
• Table 9 : Selected Companies Developing MicroRNA Therapeutics
• Table 10 : miRNA-Based Diagnostic Tools Available in Clinic
• Table 11 : Global Market for miRNA Tools, by End User, Through 2028
• Table 12 : Selected Companies Offering MiRNA Expression Profiling and Other Services
• Table 13 : Global Market for miRNA Tools for Academic and Other Research Institutes, by Technology Type, Through 2028
• Table 14 : Global Market for miRNA Tools for Life Science Industry, by Technology Type, Through 2028
• Table 15 : Global Market for miRNA Tools for miRNA Service Providers, by Technology Type, Through 2028
• Table 16 : Global Market for miRNA Tools, by Application, Through 2028
• Table 17 : Number of Publications Associated with microRNA and Diseases, 2017-2022
• Table 18 : Number of microRNA Clinical Trials by Diseases, 2017-2022
• Table 19 : Global Market for miRNA Tools for Cancer, by Technology Type, Through 2028
• Table 20 : Global Market for miRNA Tools for Cardiovascular Diseases, by Technology Type, Through 2028
• Table 21 : NIH Funding for Neuroscience Research, Through 2023
• Table 22 : Global Market for miRNA Tools for Neurological Disorders, by Technology Type, Through 2028
• Table 23 : Global Market for miRNA Tools for Metabolic Disorders, by Technology Type, Through 2028
• Table 24 : Global Market for miRNA Tools for Immune Disorders, by Technology Type, Through 2028
• Table 25 : Global Market for miRNA Tools for Other Diseases, by Technology Type, Through 2028
• Table 26 : Global Market for miRNA Tools, by Region, Through 2028
• Table 27 : North American Market for miRNA Tools, by Technology Type, Through 2028
• Table 28 : European Market for miRNA Tools, by Technology Type, Through 2028
• Table 29 : Asia-Pacific Market for miRNA Tools, by Technology Type, Through 2028
• Table 30 : RoW Market for miRNA Tools, by Technology Type, Through 2028
• Table 31 : Key Focus Areas in ESG Metrics
• Table 32 : Net-Zero GHG Commitments by Major miRNA Tools Companies
• Table 33 : ESG Rankings for Major miRNA Tools Companies, 2023*
• Table 34 : CDP Scope Card for Major miRNA Tools and Services Companies, 2022
• Table 35 : Digital PCR vs. Real-Time qPCR vs. Traditional PCR at a Glance
• Table 36 : Disease Classes Addressed, by MicroRNA Therapeutics in Clinical Trials, as of May 2023
• Table 37 : Selected Investigational miRNA-Based Therapeutic Candidates in Clinical Trials, as of May 2023
• Table 38 : Selected miRNA-based Diagnostic Tests in Development, as of May 2023
• Table 39 : Leading Market Players in miRNA Tools Market, 2022
• Table 40 : Mergers and Acquisitions of MicroRNA Tools Companies, August 2018-May 2023
• Table 41 : Abcam Plc: Annual Revenue, 2022
• Table 42 : Abcam Plc: miRNA Product Portfolio
• Table 43 : Abcam Plc: News/Key Developments, Jan 2021-May 2023
• Table 44 : Agilent Technologies Inc.: Annual Revenue, 2022
• Table 45 : Agilent Technologies Inc.: miRNA Product Portfolio
• Table 46 : Agilent Technologies Inc.: News/Key Developments, Jan 2021-May 2023
• Table 47 : Bio-Rad Laboratories Inc.: Annual Revenue, 2022
• Table 48 : Bio-Rad Laboratories Inc.: miRNA Product Portfolio
• Table 49 : Bio-Rad Laboratories Inc.: Selected Key Developments, Jan 2020-March 2023
• Table 50 : Danaher: Annual Revenue, 2022
• Table 51 : Danaher: miRNA Product Portfolio
• Table 52 : Danaher: News/Key Developments, Jan 2020-May 2023
• Table 53 : Roche: Annual Revenue, 2022
• Table 54 : Roche: miRNA Product Portfolio
• Table 55 : Roche: News/Key Developments, Jan 2021-May 2023
• Table 56 : GeneCopoeia Inc.: miRNA Product Portfolio
• Table 57 : Illumina: Annual Revenue, 2022
• Table 58 : Illumina: miRNA Product Portfolio
• Table 59 : Illumina: News/Key Developments, Jan 2021-May 2023
• Table 60 : Merck KGaA: Annual Revenue, 2022
• Table 61 : Merck KGaA: miRNA Product Portfolio
• Table 62 : Merck KGaA: News/Key Developments, Jan 2021-May 2023
• Table 63 : NanoString Technologies Inc.: Annual Revenue, 2022
• Table 64 : NanoString Technologies Inc.: miRNA Product Portfolio
• Table 65 : NanoString Technologies Inc.: News/Key Developments, Jan 2021-May 2023
• Table 66 : Qiagen: Annual Revenue, 2022
• Table 67 : Qiagen: miRNA Product Portfolio
• Table 68 : Qiagen: News/Key Developments, Jan 2021-May 2023
• Table 69 : Regulus Therapeutics LLC: News/Key Developments, Jan 2021-May 2023
• Table 70 : Thermo Fisher Scientific Inc.: Segment Information
• Table 71 : Thermo Fisher Scientific Inc.: Annual Revenue, 2022
• Table 72 : Thermo Fisher Scientific Inc.: miRNA Product Portfolio
• Table 73 : Thermo Fisher Scientific Inc.: News/Key Developments, Jan 2021-May 2023
• Table 74 : Takara Bio Inc.: Annual Revenue, 2022
• Table 75 : Takara Bio Inc.: miRNA Product Portfolio

List of Figures

• Summary Figure : Global Market for miRNA Tools, by Technology Type, 2020-2028
• Figure 1 : Resources for RNA/miRNA Extraction
• Figure 2 : Common miRNA Research Applications
• Figure 3 : miRNA Fundamental Research Questions
• Figure 4 : Bioinformatics Analysis Pipeline
• Figure 5 : miRNA Based Drugs in Clinical Trials, by Clinical Trail Phase
• Figure 6 : PubMed Article Count: "MicroRNA (miRNA)", 2014-2022
• Figure 7 : Real-time PCR microRNA Workflow
• Figure 8 : Workflow for miRNA Sequencing
• Figure 9 : miRNA Microarray Analysis Workflow
• Figure 10 : Steps for ISH
• Figure 11 : Steps for Northern Blot Analysis
• Figure 12 : Global Market for miRNA Tools, by Technology Type, 2020-2028
• Figure 13 : Global Market Shares of miRNA Tools, by Technology Type, 2022
• Figure 14 : Share of miRNA Active Clinical Trials, by Funder Type, as in May 2023
• Figure 15 : Global Market for miRNA Tools, by End User, 2020-2028
• Figure 16 : Global Market Shares of miRNA Tools, by End User, 2022
• Figure 17 : Global Market for miRNA Tools for Academic and Other Research Institutes, by Technology Type, 2020-2028
• Figure 18 : Global Market Shares of miRNA Tools for Academic and Other Research Institutes, by Technology Type, 2022
• Figure 19 : Global Market for miRNA Tools for Life Science Industry, by Technology Type, 2020-2028
• Figure 20 : Global Market Shares of miRNA Tools for Life Science Industry, by Technology Type, 2022
• Figure 21 : Global Market for miRNA Tools for miRNA Service Providers, by Technology Type, 2020-2028
• Figure 22 : Global Market Shares of miRNA Tools for miRNA Service Providers, by Technology Type, 2022
• Figure 23 : Global Market for miRNA Tools, by Application, 2020-2028
• Figure 24 : Global Market Shares of miRNA Tools, by Application, 2022
• Figure 25 : Global Market for miRNA Tools for Cancer, by Technology Type, 2020-2028
• Figure 26 : Global Market for miRNA Tools for Cardiovascular Diseases, by Technology Type, 2020-2028
• Figure 27 : NIH's AD and Related Dementia Research Funding, 2013-2023
• Figure 28 : Global Market for miRNA Tools for Neurological Disorders, by Technology Type, 2020-2028
• Figure 29 : Global Market for miRNA Tools for Metabolic Disorders, by Technology Type, 2020-2028
• Figure 30 : Global Market for miRNA Tools for Immune Disorders, by Technology Type, 2020-2028
• Figure 31 : Global Market for miRNA Tools for Other Diseases, by Technology Type, 2020-2028
• Figure 32 : Global Market for miRNA Tools, by Region, 2020-2028
• Figure 33 : Global Market Shares of miRNA Tools, by Region, 2022
• Figure 34 : Business Enterprise Expenditures on Pharmaceutical R&D and Government Budgets for Health-related R&D, 2018 (or Nearest Year)
• Figure 35 : North American Market for miRNA Tools, by Technology Type, 2020-2028
• Figure 36 : North American Market Shares of miRNA Tools, by Technology Type, 2022
• Figure 37 : Investment on Grants for Biomedical Research, by Region, 2020
• Figure 38 : European Market for miRNA Tools, by Technology Type, 2020-2028
• Figure 39 : European Market Shares of miRNA Tools, by Technology Type, 2022
• Figure 40 : Asia-Pacific Market for miRNA Tools, by Technology Type, 2020-2028
• Figure 41 : Asia-Pacific Market Shares of miRNA Tools, by Technology Type, 2022
• Figure 42 : RoW Market for miRNA Tools, by Technology Type, 2020-2028
• Figure 43 : RoW Market Shares of miRNA Tools, by Technology Type, 2022
• Figure 44 : How a Strong ESG Proposition Benefits Businesses
• Figure 45 : ESG-Adoption Level Across All the Industries, Global, 2021 and 2022
• Figure 46 : The Ten Business Sustainability Trends Identified for 2022
• Figure 47 : Research Communities' Key Sustainable Practices in Research Laboratories
• Figure 48 : Illumina Inc.'s Most Material ESG Issues
• Figure 49 : Emerging Trends/Technologies in the miRNA Tools Market
• Figure 50 : Advantages of Liquid Biopsy
• Figure 51 : Benefits of RNA Sequencing
• Figure 52 : miRNA-based Clinical Trials: "miR-", 2014-2022
• Figure 53 : miRNA Based Therapeutic Candidates in Clinical Trials
• Figure 54 : Principle Competitive Factors in microRNA Tools Market
• Figure 55 : Abcam Plc: Financials, 2021 and 2022
• Figure 56 : Abcam Plc: Revenue Share, by Type, 2022
• Figure 57 : Abcam Plc: Revenue Share, by Region, 2022
• Figure 58 : Agilent Technologies Inc.: Financials, 2021 and 2022
• Figure 59 : Agilent Technologies Inc.: Market Share, by Business Segment, 2022
• Figure 60 : Agilent Technologies Inc.: Revenue Share, by Region, 2022
• Figure 61 : Bio-Rad Laboratories Inc.: Financials, 2021 and 2022
• Figure 62 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Segment, 2022
• Figure 63 : Bio-Rad Laboratories Inc.: Revenue Share, by Region, 2022
• Figure 64 : Danaher: Financials, 2021 and 2022
• Figure 65 : Danaher: Revenue Share, by Business Segment, 2022
• Figure 66 : Danaher: Revenue Share, by Country/Region, 2022
• Figure 67 : Roche: Financials, 2021 and 2022
• Figure 68 : Roche: Revenue Share, by Business Segment, 2022
• Figure 69 : Illumina: Financials, 2021 and 2022
• Figure 70 : Illumina: Revenue Share, by Business Segment, 2022
• Figure 71 : Illumina: Revenue Share, by Region, 2022
• Figure 72 : Merck KGaA: Financials, 2021 and 2022
• Figure 73 : Merck KGaA: Market Share, by Business Segment, 2022
• Figure 74 : Merck KGaA: Revenue Share, by Region, 2022
• Figure 75 : NanoString Technologies Inc.: Financials, 2021 and 2022
• Figure 76 : NanoString Technologies Inc.: Market Share, by Business Segment, 2022
• Figure 77 : NanoString Technologies Inc.: Revenue Share, by Region, 2022
• Figure 78 : Qiagen: Financials, 2021 and 2022
• Figure 79 : Qiagen: Revenue Share, by Product Type, 2022
• Figure 80 : Qiagen: Revenue Share, by Region, 2022
• Figure 81 : Thermo Fisher Scientific Inc.: Financials, 2021 and 2022
• Figure 82 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Segment, 2022
• Figure 83 : Thermo Fisher Scientific Inc.: Revenue Share, by Region, 2022
• Figure 84 : Takara Bio Inc.: Financials, 2021 and 2022
• Figure 85 : Takara Bio Inc.: Revenue Share, by Product, 2022
• Figure 86 : Takara Bio Inc.: Revenue Share, by Country/Region, 2022